Increased overall antibiotic susceptibility in Staphylococcus aureus femAB null mutants.
The staphylococcal pentaglycine side chain of the peptidoglycan is reduced to one glycine in femAB null mutants. This is associated with increased susceptibility to methicillin and to a whole range of unrelated antibiotics as well. Genetic evidence suggests that femAB null mutants are only viable because of a compensatory mutation in an unlinked site.
Ling
B
B
Institute of Medical Microbiology, University of Zürich, Switzerland.
Berger-Bächi
B
B
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D005798:Genes, Bacterial / Q000235:genetics*; D016106:Methicillin Resistance / Q000235:genetics; D008826:Microbial Sensitivity Tests; D009154:Mutation / Q000235:genetics; D010457:Peptidoglycan / Q000235:genetics / Q000378:metabolism; D015183:Restriction Mapping; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000235:genetics*
D000900:Anti-Bacterial Agents; D010457:Peptidoglycan